Street Calls of the Week
Enlivex Therapeutics Ltd. (NASDAQ:ENLV), a biotechnology company with current revenues of $4.83 million and an InvestingPro Financial Health rating of FAIR, announced Thursday that it will hold its Annual General Meeting of Shareholders on Monday, November 10, 2025, at 7:00 p.m. Israel time. The meeting will take place at the company’s offices located at 14 Einstein Street, Nes Ziona, Israel.
The company provided notice of the meeting and a proxy statement, along with a form of proxy card, as attachments to its latest filing with the U.S. Securities and Exchange Commission. Details regarding the agenda and matters to be voted on were not included in Thursday’s announcement but are available in the referenced documents.
This information is based on a press release statement included in Enlivex Therapeutics’ recent SEC filing.
In other recent news, Mega Matrix Inc. announced that its shareholders have approved significant changes to the company’s share capital structure. At an Extraordinary General Meeting in Singapore, a resolution was passed to increase the authorized share capital to $1,110,000. This adjustment includes the addition of 900,000,000 class A ordinary shares and 40,000,000 class B ordinary shares, along with the creation of 50,000,000 new class C ordinary shares. The company also introduced 10,000,000 preferred shares, all with a par value of $0.001 each. Meanwhile, B.O.S. Better Online Solutions Ltd. has scheduled its annual shareholder meeting for October 23, 2025. The company has released its proxy statement and form of proxy card in connection with the meeting, though the specific matters to be discussed or voted upon have not been disclosed. These developments reflect ongoing strategic moves by both companies in their corporate governance and capital management efforts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.